What Is The Long-Term Forecast For The Global Cancer Anorexia-Cachexia Syndrome (CACS) Market Growing At 10.5% CAGR?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Cancer Anorexia-Cachexia Syndrome (CACS) Industry By 2029?
The market for the cancer anorexia-cachexia syndrome (CACS) has expanded swiftly in recent years. It is projected to rise from a $3.51 billion value in 2024 to approximately $3.88 billion by 2025, with a compound annual growth rate (CAGR) pegged at 10.7%. Factors such as an increase in cancer occurrences, heightened awareness among healthcare providers, an emphasis on improving the life quality of cancer patients, growth in clinical trials, and collaborations and partnerships in the pharmaceutical field have contributed to the growth noted in the historical period.
Expectations are high for a swift expansion in the cancer anorexia-cachexia syndrome (cacs) market in the upcoming years. The market is predicted to touch the $5.79 billion mark by 2029, exhibiting a compound annual growth rate (CAGR) of 10.5%. The projected growth during this period is attributed to factors including improved cancer survival rates, an upward trend in investments related to oncology supportive care, advancement in personalized medicine, an intensified focus on multimodal therapies, and enhancing healthcare infrastructure. The future period will likely witness significant trends such as progression in palliative care, creation of targeted therapies, innovative advancements in drug delivery systems, the integration of AI in drug development, and the expansion of personalized medicine.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21125&type=smp
Which Factors Are Steering Growth In The Cancer Anorexia-Cachexia Syndrome (CACS) Market?
The escalating occurrence of cancer is anticipated to drive the expansion of the cancer anorexia-cachexia syndrome market in the future. Cancer encompasses a wide range of diseases marked by the unchecked proliferation and dissemination of anomalous cells within the human body. Globally, cancer instances are on the rise due to elements such as an aging demographic, alterations in lifestyles, environmental influences, advancements in detection techniques, heightened awareness, as well as genetic susceptibilities and infections linked to specific types of cancer. Cancer anorexia-cachexia syndrome’s (CACS) primary aim is to manage the pronounced weight reduction and malnutrition frequently observed in cancer patients, thereby enhancing their overall quality of life and treatment results. Take, for example, a report released in August 2024 by Macmillan Cancer Support, a UK-based charity, that pointed out the cancer prevalence in the UK, with over 3 million people battling the disease. The report projected an increase in this number to 3.5 million by 2025, reaching 4 million by 2030, and finally touching 5.3 million by 2040. Consequently, the escalating occurrence of cancer is fueling the expansion of the cancer anorexia-cachexia syndrome market.
Which Segment Accounts For The Largest Share In The Cancer Anorexia-Cachexia Syndrome (CACS) Market?
The cancer anorexia-cachexia syndrome (cacs)market covered in this report is segmented –
1) By Indication: Weight Loss Prevention; Appetite Loss; Muscle Wasting; Inflammation; Other Indications
2) By Therapeutics: Progestogen; Corticosteroid; Combination Therapy; Other Therapeutics
3) By Mechanism Of Action: Appetite Stimulants; Anti-inflammatory Agents; Hormone Therapies; Cannabinoids; Other Mechanism Of Actions
4) By Route of Administration: Oral; Intravenous; Subcutaneous; Transdermal; Other Route of Administration
5) By Application: Hospitals; Clinics; Home Care
Subsegments:
1) By Weight Loss Prevention: Nutritional Supplements; Metabolic Modulators
2) By Appetite Loss: Appetite Stimulants; Ghrelin Receptor Agonists
3) By Muscle Wasting: Anabolic Agents; Selective Androgen Receptor Modulators (SARMs)
4) By Inflammation: Anti-Inflammatory Drugs; Cytokine Inhibitors
5) By Other Indications: Combination Therapies; Supportive Care Interventions
What Strategic Shifts And Innovations Are Influencing The Cancer Anorexia-Cachexia Syndrome (CACS) Market?
Leading businesses in the cancer anorexia-cachexia syndrome market are prioritizing the creation of novel solutions like monoclonal antibody therapies. These solutions aim to increase the effectiveness of treatments, improve patient prognosis, and fulfill unresolved clinical requirements. The therapies involve using lab-developed antibodies that aim at specific antigens on cancer cells, thus aiding the immune system in identifying and more efficiently attacking these cells. Pfizer Inc., a pharmaceutical and biotech firm based in the US, for instance, reported encouraging results from a Phase II study for ponsegromab, a monoclonal antibody that targets Growth/Differentiation Factor 15 (GDF-15) in September 2024. The promising data from the trial paves the way for a fresh treatment path for individuals suffering from this distressing condition, as there are currently very few effective treatments available. The Phase 2 trial results indicate significant advancements in tackling the underlying inflammatory causes leading to muscle atrophy and weight reduction in cancer patients. The focus of this treatment strategy isn’t only to enhance physical function but also to improve the general life quality of cancer patients—an important breakthrough in cancer treatment.
Who Are The Dominant Players In The Cancer Anorexia-Cachexia Syndrome (CACS) Market Today?
Major companies operating in the cancer anorexia-cachexia syndrome (CACS) market are Pfizer Inc., Merck & Co. Inc., Ono Pharmaceutical Co. Ltd., Mundipharma International Limited, Yuhan Corporation, Helsinn Healthcare SA, AVEO Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Larix Bioscience LLC, Aeterna Zentaris Inc., Artelo Biosciences Inc., Sapphire Therapeutics Inc., Endevica Bio, AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Betula Pharmaceuticals AB, Cannabics Pharmaceuticals Inc., Creative Medical Technology Holdings Inc., Abreos Biosciences Inc.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Cancer Anorexia-Cachexia Syndrome (CACS) Market?
North America was the largest region in the cancer anorexia-cachexia (CACS) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer anorexia-cachexia syndrome (CACS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21125&type=smp
Browse Through More Reports Similar to the Global Cancer Anorexia-Cachexia Syndrome (CACS) Market 2025, By The Business Research Company
Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Bladder Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report
Blood Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
